Oral Prolonged-Release Ketamine for Treatment-Resistant Depression: Two Randomized Clinical Trials. | ClinicLens
Ketamine exerts rapid antidepressant effects. However, currently available ketamine-based treatments are associated with dissociative and cardiovascular adverse effects. To evaluate the antidepressant efficacy and tolerability of KET01, a novel, oral, prolonged-release racemic ke
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.